While in prostate cancer PC3 cells of human beings, the low expression of miR-1296 can upregulate both minichromosome maintenance 2 (MCM2) mRNA and protein, and conversely, its overexpression can lower the level of the both and even shorten the S phase of the cell cycle [6]. The gene discussed is MCM2; the disease is prostate carcinoma.